| MR编号 | PT/H/2119/002 |
|---|
| 药品名称 | Imipenem/Cilastatin Kabi 500 mg/500 mg powder for solution for infusion |
|---|
| 活性成分 | - Cilastatin sodium salt 250.0 mg
- Imipenem monohydrate 250.0 mg
|
|---|
| 剂型 | Powder for solution for infusion |
|---|
| 上市许可持有人 | FRESENIUS KABI LIMITED |
|---|
| 参考成员国 - 产品名称 | Portugal (PT) |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
- United Kingdom (Northern Ireland) (XI)
PL 08828/0190 - 0022 + PL 08828/0185 - 0018 - Netherlands (NL)
- Luxembourg (LU)
- Austria (AT)
Imipenem/Cilastatin Kabi 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung - France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Poland (PL)
Imipenem / Cilastatin Kabi - Hungary (HU)
- Czechia (CZ)
IMIPENEM/CILASTATIN KABI 250 MG/250 MG - Slovakia (SK)
- Romania (RO)
Imipenem/Cilastatin Kabi 500 mg/500 mg pulbere pentru soluţie perfuzabilă - Ireland (IE)
- Bulgaria (BG)
- Estonia (EE)
- Slovenia (SI)
|
|---|
| 许可日期 | 2009/07/16 |
|---|
| 最近更新日期 | 2025/01/14 |
|---|
| 药物ATC编码 | - J01DH51 imipenem and cilastatin
|
|---|
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|